Skip to main content
Watch Insiders
IAMSector not reported

Iambic Therapeutics, Inc. (IAM) Insider Trading

In the last 90 days, 1 Iambic Therapeutics, Inc. (IAM) insider reported 1 open-market purchase totaling $11,500,000 and no sales. The most recent open-market purchase was reported on Oct 16, 2026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$11,500,000
Corporate buyers
1
Latest transaction
Oct 16, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 16, 2026Evan Lockwood RachlinDirectorOpen Market Purchase718,750$16.00$11,500,000

Common questions

IAM insider trading FAQ

Are IAM insiders buying or selling?
Over the last 90 days, IAM insiders were net buyers, reporting $11,500,000 of open-market purchases and $0.00 of sales.
When was the last IAM insider purchase?
The most recent open-market purchase of Iambic Therapeutics, Inc. stock by an insider was reported on Oct 16, 2026, one of 1 purchase in the last 90 days.
Where does IAM insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Iambic Therapeutics, Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.